Human Herpesvirus 6 Encephalitis in Patients Administered Mycophenolate Mofetil as Prophylaxis for Graft ‐versus‐Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation

ConclusionsMMF may have the potential to increase the frequency of severe HHV ‐6 encephalitis in patients undergoing CBT and non‐CBT. Thus, MMF should be administered with caution, and patients should be monitored closely for HHV‐6 encephalitis even those who did not undergo CBT.This article is protected by copyright. All rights reserved.

Source: Transplant Infectious Disease - November 10, 2018 Category: Transplant Surgery Authors: Yumiko Inui, Kimikazu Yakushijin, Atsuo Okamura, Yasuhiro Tanaka, Isaku Shinzato, Tetsuhiko Nomura, Hiroya Ichikawa, Yu Mizutani, Akihito Kitao, Keiji Kurata, Seiji Kakiuchi, Yoshiharu Miyata, Yukinari Sanada, Koichi Kitagawa, Kiyoaki Uryu, Tags: Original Report Source Type: research